Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders Transcript - Thomson StreetEvents

Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders Transcript

Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders Transcript - Thomson StreetEvents
Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders Transcript
Published Oct 17, 2023
20 pages (16734 words) — Published Oct 17, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of VVY.AS corporate analyst meeting

  
Brief Excerpt:

...(technical difficulty) Discussion on the design and rationale of the VIVIAD Phase 2b study of our lead program, varoglutamstat in Alzheimer's disease. We are very pleased to be joined by our moderator of today's event, Dr. Philip Scheltens, in addition to guest speakers, Dr. Stephan Schilling, Dr. John Harrison, Dr. Sietske Sikkes and Dr. Willem de Haan. Following the moderated discussion and brief presentations, we will host a Q&A session. As a reminder, you are welcome to submit questions in advance via the webcast portal. You can find the respective tab in the upper right corner of the webcast player. Next slide, please. Before we start, I would like to remind you that during this conference call, we will present and discuss certain forward-looking statements concerning the development of Vivoryon's core technologies, the progress of its current research and development programs and the initiation of additional programs. Should actual results differ from company's assumptions, ensuing...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Vivoryon Therapeutics NV
Ticker
VVY.AS
Time
11:30am GMT
Format:
PDF Adobe Acrobat
Buy Now

Half Year 2023 Vivoryon Therapeutics NV Earnings Call Transcript – 2023-09-07 – US$ 54.00 – Edited Transcript of VVY.AS earnings conference call or presentation 7-Sep-23 1:00pm GMT

Vivoryon Therapeutics NV Q4 2022 Earnings Call Transcript – 2023-04-19 – US$ 54.00 – Edited Transcript of VVY.AS earnings conference call or presentation 19-Apr-23 1:00pm GMT

Vivoryon Therapeutics NV at Barclays Global Healthcare Conference Transcript – 2023-03-16 – US$ 54.00 – Edited Transcript of VVY.AS presentation 16-Mar-23 12:00pm GMT

Vivoryon Therapeutics NV Q3 2022 Earnings Call Transcript – 2022-11-22 – US$ 54.00 – Edited Transcript of VVY.AS earnings conference call or presentation 22-Nov-22 2:00pm GMT

Vivoryon Therapeutics NV Q2 2022 Earnings Call Transcript – 2022-09-30 – US$ 54.00 – Edited Transcript of VVY.AS earnings conference call or presentation 30-Sep-22 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders Transcript" Oct 17, 2023. Alacra Store. May 06, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Vivoryon-Therapeutics-NV-at-Virtual-R-D-Event-with-Key-Opinion-Leaders-T15763971>
  
APA:
Thomson StreetEvents. (2023). Vivoryon Therapeutics NV at Virtual R&D Event with Key Opinion Leaders Transcript Oct 17, 2023. New York, NY: Alacra Store. Retrieved May 06, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Vivoryon-Therapeutics-NV-at-Virtual-R-D-Event-with-Key-Opinion-Leaders-T15763971>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.